Kurma Partners Biofund IV
Share
N°01 / About
About Kurma Partners Biofund IV
Kurma Partners closes €215M Biofund IV, crossing €1B AUM on back of four big pharma exits. Invests in European biotech and biopharma companies at Series A and B stages.
N°02 / Thesis
Investment Focus
Location / RegionFrance
Funding StageGrowth
Industry Focus
Biotech
Therapeutics
Investor Signals Profile
active
Sweet Spot
Scientific founder or academic researcher in European therapeutics targeting severe or rare disease
24 signals on Kurma Partners Biofund IV
9 bullish · 3 contrarian · 5 pitch do's · 3 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.